E Fund Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

E Fund Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,717	Closed	-$461K	–	328
2023 Q2	$461K	Sell	11,717 -6,196	-35%	-$219K	0.04%	124
2023 Q1	$436K	Sell	17,913 -2,966	-14%	-$64.9K	0.03%	143
2022 Q4	$447K	Sell	20,879 -4,745	-19%	-$101K	0.04%	154
2022 Q3	$460K	Sell	25,624 -14,577	-36%	-$191K	0.04%	139
2022 Q2	$387K	Buy	40,201 +23,831	+146%	+$299K	0.04%	194
2022 Q1	$276K	Buy	16,370 +4,542	+38%	+$67.1K	0.01%	227
2021 Q4	$198K	Buy	+11,828	New	+$194K	0.01%	266

E Fund Management's ISEE Position: Q3 2023 in Review

E Fund Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 11,717 shares — an estimated $461K sold.

E Fund Management first reported a position in ISEE in Q4 2021 and held it in 7 quarters. The position peaked at $461K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

E Fund Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
E Fund Management sold 11,717 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $461K.
E Fund Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
E Fund Management's IVERIC bio, Inc. Common Stock position peaked at $461K in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on E Fund Management's 13F filing for Q3 2023, filed 13 Nov 2023.